Register
Question 1
Which cell surface marker is deficient in paroxysmal nocturnal hemoglobinuria?
Correct Answer:
CD55
Explanation:
In paroxysmal nocturnal hemoglobinuria (PNH), there is a deficiency of specific cell surface markers due to mutations in the PIGA gene, which leads to a lack of glycosylphosphatidylinositol (GPI)-anchored proteins. CD55, also known as decay-accelerating factor (DAF), is one of these GPI-anchored proteins. Its primary role is to regulate the complement system and prevent complement-mediated lysis of red blood cells. In patients with PNH, the absence of CD55 on the surface of erythrocytes renders them susceptible to uncontrolled complement activation, resulting in hemolysis and the release of hemoglobin into the urine, which is characteristic of the condition. This lack of protective factors on the cell surface is fundamental to understanding the pathology of PNH, as it highlights the immunological mechanisms that lead to the anemia and associated symptoms seen in affected individuals. In contrast, the other markers listed do not have the same direct association with PNH. CD16, CD45, and CD95 are not GPI-anchored proteins and are not deficient in this specific hematological disorder. Their roles are related to other immune functions or cell signaling pathways, making
Question 2
A 4-year-old boy presents with an itchy rash and chronic diarrhea. What conditions does he likely have?
Correct Answer:
Dermatitis herpetiformis and celiac disease
Explanation:
The presentation of an itchy rash and chronic diarrhea in a 4-year-old boy strongly suggests possible celiac disease, particularly when paired with dermatitis herpetiformis, which is a classic skin manifestation associated with this intestinal condition. Celiac disease arises due to an abnormal immune response to gluten, leading to inflammation and malabsorption in the intestines, which perfectly correlates with chronic diarrhea. Dermatitis herpetiformis is characterized by a blistering, itchy rash that often appears symmetrically on the elbows, knees, and buttocks. Its association with celiac disease is well-documented, making this combination likely when the symptoms of skin irritation and gastrointestinal distress present together. Other conditions listed do not match the clinical picture as closely. For example, while atopic dermatitis is indeed associated with itching and eczema-like rashes, it does not typically involve diarrhea as a prominent feature unless other gastrointestinal conditions are also present. Crohn's disease can lead to diarrhea but is less likely to cause a related itchy rash. Hives and ulcerative colitis also do not logically connect the symptoms of an itchy rash and chronic diarrhea in the same manner as dermatitis herpetiformis and celiac disease do. Therefore, the combination of dermatitis herpetiform
Question 3
Which test for CGD diagnosis is mostly a qualitative measurement of NADPH oxidase activity?
Correct Answer:
NBT test
Explanation:
The NBT (nitroblue tetrazolium) test is primarily a qualitative measurement of NADPH oxidase activity, specifically assessing the capacity of neutrophils to produce reactive oxygen species (ROS). In patients with Chronic Granulomatous Disease (CGD), there is a defect in the NADPH oxidase enzyme complex, which leads to an inability of phagocytes to generate superoxide and other ROS. During the NBT test, neutrophils are stimulated, and in normal individuals, they will reduce NBT to formazan, indicating the presence of functioning NADPH oxidase activity. Conversely, in individuals with CGD, there is a lack of color change, demonstrating the impaired ability to produce the ROS necessary for NBT reduction. While other tests, such as flow cytometry and dihydrorhodamine 123, also assess oxidative burst activity and may provide more quantitative results, the NBT test's primary function as a qualitative measure of NADPH oxidase activity in the context of CGD diagnosis makes it stand out. Therefore, the specificity of the NBT test in evaluating the functional defect inherent in CGD is pivotal for diagnosis and understanding the underlying pathophysiology of the disease.
Question 4
Which cytokine is a crucial growth factor for B cells and T cells and is produced by stromal cells in bone marrow and thymus?
Correct Answer:
Interleukin 7 (IL-7)
Explanation:
Interleukin 7 (IL-7) plays a critical role as a growth factor for both B cells and T cells, supporting their development and survival. This cytokine is primarily produced by stromal cells located in the bone marrow and thymus, which are essential sites for hematopoiesis and lymphocyte maturation. IL-7 acts on precursor cells, helping to initiate the process of lymphocyte differentiation and proliferation. In the bone marrow, it is important for the development of B cells from common lymphoid progenitors. Similarly, in the thymus, IL-7 is essential for the proliferation and maturation of T cell precursors. The interaction of IL-7 with its receptor on these cells is crucial for maintaining their viability and advancing through various stages of development. Other cytokines mentioned, such as Interleukin 6, Interleukin 2, and Interleukin 3, have different roles in the immune response and hematopoiesis. For instance, IL-6 is primarily involved in inflammatory responses and is important for B cell differentiation into antibody-secreting plasma cells, but it is not specifically a growth factor for T and B cell development like IL-7. Interleukin 2 is mainly produced by
Question 5
What type of immunoglobulin can activate the alternative complement pathway?
Correct Answer:
IgA
Explanation:
The correct answer relates to the role of immunoglobulins in the activation of the alternative complement pathway. The alternative complement pathway can be activated by the presence of certain immunoglobulins and other factors, but it is particularly noted for its activation by polysaccharide structures on microbial surfaces rather than directly through immunoglobulins like IgA, IgG, IgM, or IgE. In the context of the alternative pathway, while IgG can engage with complement components, IgM is most notable for its ability to activate complement through the classical pathway due to its structure allowing effective binding and triggering. IgA is predominantly found in mucosal areas and provides protection against pathogens on mucosal surfaces, but it does not significantly activate the alternative pathway. The alternative pathway's activation proceeds through factors such as C3 and factor B, which amplify the complement response and enhance opsonization of pathogens, even in the absence of antibodies, as it serves as a first line of defense. While immunoglobulins typically activate the classical pathway (IgM and IgG), IgA’s role does not extend in the same manner to the alternative pathway. Therefore, for the activation of the alternative complement pathway, the focus doesn't specifically lie on any of the
Question 1
Exam overview

About this Exam

The ACAAI Board Practice Exam is an essential self-assessment and study tool tailored for physicians aiming for certification or maintenance of certification by the American Board of Allergy and Immunology (ABAI). Designed primarily for allergy/immunology fellows and practicing specialists, this practice exam mirrors the format and rigor of the actual board exam. It allows candidates to gauge their understanding of core concepts, identify areas of weakness, and become familiar with the types of questions they will encounter. Achieving certification signifies a physician’s commitment to providing the highest quality patient care in allergy, asthma, and immunology.

More details

Additional Information

What the Course Entails and Exam Details

While not a conventional "course" with a fixed syllabus, the preparation path the ACAAI Board Practice Exam supports is a comprehensive curriculum that covers the entire spectrum of allergy and immunology. The practice exam, and the board exam itself, reflect this deep and broad knowledge base, ensuring candidates are proficient in:

  • Basic and Clinical Immunology: The foundational principles of the immune system’s function, including immune cell development, antibody production, hypersensitivity reactions, and the mechanisms behind immunodeficiencies.

  • Allergic Conditions: Comprehensive knowledge of diagnosing and managing diverse conditions such as allergic rhinitis, asthma, atopic dermatitis (eczema), food and drug allergies, insect sting allergies, and anaphylaxis.

  • Immunologic Diseases: Understanding and management of non-allergic immunologic conditions, including primary and secondary immunodeficiency disorders.

  • Diagnostic Techniques: Expertise in a variety of diagnostic procedures essential for the field, including skin testing, pulmonary function tests, bronchial challenges, and interpretations of complex laboratory data.

  • Management Strategies: Familiarity with current evidence-based treatment guidelines, including pharmacotherapy, allergen immunotherapy, biologics, and patient education.

The ACAAI Board Practice Exam is carefully constructed to touch upon each of these critical domains, providing a realistic test-taking experience that reinforces knowledge and boosts confidence.


What to Expect in the Final Exam

The ultimate goal for most users of the ACAAI practice resources is successful completion of the secure, proctored computer-based certification examination administered by the ABAI. This final exam is typically held annually and is meticulously designed to assess:

  • Format: The exam predominantly consists of objective, multiple-choice questions with one best answer. These questions are designed to test not just recall, but interpretive skills, problem-solving abilities, and sound clinical judgment across adult and pediatric populations.

  • Structure: While exact specifics may vary, expect a demanding, multi-hour examination divided into multiple sections or sessions. Some boards also incorporate applied or practical components where relevant.

  • Passing Score: The ABAI uses a criterion-referenced standard for scoring, which means the passing score is predetermined based on the expected performance of a competent allergist/immunologist. The difficulty of the questions is factored in, making each version of the exam fair and reflective of the core competency expected.

  • Rules & Security: This is a high-stakes professional exam with strict security protocols. Candidates must adhere to all rules, including providing proper identification, undergoing security screening, and not bringing unauthorized items into the testing room. Irregular behavior can lead to serious consequences.


How to Study and Exam Centers

Preparation is a long-term process that starts during fellowship and continues right up until the final exam date. Here’s a strategic approach:

  • Incorporate Practice Exams Early and Often: Treat the ACAAI Board Practice Exam as a regular part of your study routine. Use it initially to assess your baseline, and subsequently to mark progress and focus efforts. The realistic question format is invaluable for understanding the style of testing you will face.

  • Utilize the ACAAI Board Review Book: ACAAI publishes a comprehensive Board Review for the Allergy and Immunology Boards. This resource is frequently structured to match the exam blueprint and is a staple for in-depth knowledge review.

  • Join Study Groups: Working with peers allows for discussion, clarification of complex topics, and moral support during the challenging prep phase.

  • Attend Review Courses: Consider participating in official ACAAI review courses, often held live or available on-demand, where experts provide key insights and focused content reviews.

  • Schedule Consistent Study: Dedicate specific times in your week to study. Consistency is key to long-term memory retention and effective topic coverage.

  • Simulate Exam Conditions: When taking the ACAAI Board Practice Exam, try to replicate the real testing environment – minimize distractions, use a quiet space, and time yourself where possible.

Taking the Practice and Final Exams:

  • ACAAI Board Practice Exam: You can typically access this directly through the ACAAI website. It’s often an online resource available as a benefit of ACAAI membership or available for separate purchase. There is no physical testing center required for the practice exam itself.

  • Final ABAI Board Exam: The actual certification and MOC exams are administered at secure, professional testing centers across the country, often via platforms like Pearson VUE. Candidates must formally apply to the ABAI, receive approval, and then schedule their testing appointment at an authorized center of their choice during the designated testing window. Detailed information and a full list of available testing locations will be provided by the ABAI upon approval. Ensure you book your spot early, as slots at preferred locations can fill up.


Job Opportunities from the Course

Becoming a certified Specialist in Allergy and Immunology, a path culminating in passing the board exam, unlocks a rewarding career in medicine. Potential job titles and career paths include:

  • Allergy and Immunology Specialist (Clinical Practice): Working in a private practice, a multi-specialty group, or a hospital clinic to provide expert care to children and adults with a wide range of allergic and immunologic conditions.

  • Pediatric Allergist / Immunologist: Specializing within a children's hospital or clinic, focusing exclusively on the unique needs of infants, children, and adolescents with allergy and immune disorders.

  • Academic Physician / Researcher (Allergy/Immunology): Conducting leading-edge research, teaching medical students and fellows, and providing clinical care in a university hospital or medical center.

  • Clinical Immunologist: Working in settings focused on immunodeficiency diseases and immune-mediated conditions.

  • Consultant in Medical Industry: Utilizing expertise to contribute to drug development, medical device creation, or clinical trial design and oversight.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

10th Brigade Engineer Battalion (10BEB) Board Practice Exam

0 min

1-67 AR Death Dealers Board Practice Test

0 min

1‑502 NCO and Soldier of the Month Board Practice Exam

0 min

Architectural Planning Board Practice Exam

0 min

Architecture Board Exam - Site Planning Practice] Practice Exam

0 min

5-20 Infantry Board Practice Test

0 min